July 23, 2021 As public health officials keep track of the contagious Delta variant of COVID-19 across the U.S., the CDC is also watching for a potential outbreak of another virus — monkeypox. More than 200 people in 27 states are being monitored for possible exposure after they had contact with an American who contracted… Read More »
Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. Their findings were published on Friday, June 24, in The Lancet. “CAR-T cell therapy is a type of immunotherapy that involves harnessing the power of a person’s own immune system by engineering… Read More »
A new, detailed model of the surface of the SARS-CoV-2 spike protein reveals previously unknown vulnerabilities that could inform development of vaccines. Mateusz Sikora of the Max Planck Institute of Biophysics in Frankfurt, Germany, and colleagues present these findings in the open-access journal PLOS Computational Biology. SARS-CoV-2 is the virus responsible for the COVID-19 pandemic.… Read More »
Some Canadian doctors appear to have been snapping up a malaria drug for their own possible use against COVID-19, part of a surge in prescriptions for the medicine that has health-care regulators across the country concerned. Professional organizations in several provinces have issued statements in recent days discouraging the practice, noting there’s no solid evidence… Read More »
As the COVID-19 pandemic swells, experts around the globe are working to determine which existing medicines might help patients experiencing severe illness. Malaria drug chloroquine has gotten a lot of the attention, but now a team suggests a Roche stroke drug is worth exploring. In an article in the Journal of Trauma and Acute Care Surgery, authors wrote that tissue plasminogen activator, or… Read More »